US 11945872
Anti-ACVR1 antibodies and uses thereof
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 11945872 (Anti-ACVR1 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P